China has introduced new limits on medical devices imported from the European Union. This step increases tensions between Beijing and Brussels. The Finance Ministry announced the decision on Sunday through local state media. The action responds to a recent move by the EU to keep Chinese companies out of public medical equipment bids.
The change means EU firms may now find it harder to sell their devices to Chinese state-run hospitals. Government-backed procurement projects will give less preference to products from European companies. This shift could hurt EU-based health-tech brands that rely on Chinese orders for growth.
Earlier, the EU decided to bar Chinese firms from joining tenders for some healthcare equipment. Officials said the step aimed to protect local jobs and fair competition. They pointed to China’s lack of open access for European firms in its own markets.
In response, China said the EU’s policy was unfair and damaging. The Chinese Finance Ministry stated that such actions “disrupt mutual trust and business balance.” China now plans to apply tighter rules on imported European devices in state-linked medical projects.
The dispute highlights growing trade friction between the two sides. The EU and China are major economic partners but have often clashed over market access, product standards, and subsidies. Recent talks have failed to bring about a clear agreement on fair procurement practices.
Analysts say the new limits will likely hit EU companies in the short term. Leading European firms in the medical sector may see delays or cancellations in Chinese orders. Products used in surgeries, diagnostics, and elderly care may face tougher checks or even be excluded from bids.
Smaller companies could suffer even more. Without the resources to shift focus to other markets, they may lose key revenue. Trade experts note that the rules may not block all EU goods, but the message is clear—China wants more control over who supplies its hospitals.
The EU is expected to review the move and discuss a response. Some officials have called for a measured reaction to avoid a full-scale trade war. Others argue that the bloc must stand firm against what they see as unfair tactics from Beijing.
Business groups in Europe say they hope both sides can return to the table. They stress that medical devices are key to public health and should not become tools in a political fight. Industry leaders warn that limits on trade may slow innovation and increase costs for both sides.
China’s new rules come as part of a wider trend of economic tightening. The country has been pushing for more local production and self-reliance in key sectors, including health care. Reducing dependence on foreign tech and devices has been a top policy goal.
For now, the change adds pressure to an already tense trade link. European medical firms must decide how to adapt—either by shifting focus to other regions or by trying to meet China’s new local standards. The EU, in turn, faces a test of how it defends its industries while keeping trade ties open.
Trade experts believe this clash may grow if no quick solution is found. With global markets watching, both sides will need to weigh the cost of deepening the rift.
